Kate M Johnson

17PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersDecision makingPharmacogenomicsRespiratory diseasesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 08, 2026
Risk prediction for lung cancer screening: a systematic review and meta-regression.

|Nov 21, 2025
The 'Values in Modelling' Framework for Patient and Public Involvement in Health Economics Modelling: Development and Application in the LEAP Model Project.

Stephanie Harvard, Rachel Carter, Sian Hoe Cheong

|Nov 19, 2025
Guideline-concordant inhaled medication use in COPD: a systematic review of definitions used in administrative health data.

Yiwei Yin, Valerie Mok, Jaden Jeong

|Aug 19, 2025
Factors associated with guideline-concordant maintenance inhaled medication for COPD: a population-based, longitudinal cohort study.

Yiwei Yin, Jeenat Mehareen, Mohsen Sadatsafavi

|Aug 06, 2024
The Impact of Eliminating Out-of-Pocket Payments on Asthma Medication Use.

Kate M Johnson, Lucy Cheng, Yiwei Yin

|Apr 05, 2024
Benefit-Harm Analysis of Earlier Initiation of Triple Therapy for Prevention of Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.

Rachael Mountain, Kevin I Duan, Kate M Johnson

Pageof 3

Frequent Collaborators

3 joint publications

Anirban Basu

3 joint publications

Beth Devine

3 joint publications

Mohsen Sadatsafavi

2 joint publications

Kevin I Duan